[ad_1]
Vials labeled “VACCINE Coronavirus COVID-19” and a syringe are seen in front of a displayed Novavax logo in this illustration taken December 11, 2021. REUTERS/Dado Ruvic/Illustration
Register now for FREE unlimited access to Reuters.com
Register
Feb 14 (Reuters) – Novavax Inc. (NVAX.O) said on Monday it had received interim authorization from the Singapore Health Sciences Authority (HSA) for its COVID-19 vaccine in adults.
Register now for FREE unlimited access to Reuters.com
Register
Reporting by Dania Nadeem in Bengaluru
Our Standards: The Thomson Reuters Trust Principles.
.
|
Sources 2/ https://www.reuters.com/world/asia-pacific/novavax-covid-vaccine-gets-interim-authorization-singapore-2022-02-14/ The mention sources can contact us to remove/changing this article |
[ad_2]